The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Janssen COVID-19 Vaccine - United States, February 2021

被引:114
作者
Oliver, Sara E. [1 ]
Gargano, Julia W. [1 ]
Scobie, Heather [1 ]
Wallace, Megan [1 ,2 ]
Hadler, Stephen C. [1 ]
Leung, Jessica [1 ]
Blain, Amy E. [1 ]
McClung, Nancy [1 ]
Campos-Outcalt, Doug [3 ]
Morgan, Rebecca L. [4 ]
Mbaeyi, Sarah [1 ]
MacNeil, Jessica [1 ]
Romero, Josi R. [5 ]
Talbot, H. Keipp [6 ]
Lee, Grace M. [7 ]
Bell, Beth P. [8 ]
Dooling, Kathleen [1 ]
机构
[1] CDC, COVID 19 Response Team, Atlanta, GA 30333 USA
[2] CDC, Epidem Intelligence Serv, Atlanta, GA 30333 USA
[3] Univ Arizona, Coll Med, Phoenix, AZ USA
[4] Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada
[5] Arkansas Dept Hlth, Little Rock, AR 72205 USA
[6] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA
[7] Stanford Univ, Sch Med, Stanford, CA USA
[8] Univ Washington, Seattle, WA 98195 USA
来源
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT | 2021年 / 70卷 / 09期
基金
美国国家卫生研究院;
关键词
D O I
10.15585/mmwr.mm7009e4
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
[No abstract available]
引用
收藏
页码:329 / 332
页数:4
相关论文
共 6 条
[1]  
Advisory Committee on Immunization Practices, 2021, ACIP M INF ATL GA US
[2]  
Advisory Committee on Immunization Practices, 2020, ADV COMM IMM PRACT G
[3]  
FDA, 2021, JANSS COVID 19 VACC
[4]  
Food and Drug Administration, 2021, EM US AUTH EUA JANSS
[5]  
Food and Drug Administration, 2021, COVID 19 VACC
[6]  
Vaccines and Related Biological Products Advisory Committee, 2021, VACC REL BIOL PROD A